桑加莫生物科学 SGMO 深 沪
已收盘 09-19 16:00:00 美东时间
0.90
+0.063
+7.51%
华盛通- 最 高0.94
- 今 开0.85
- 成交量 502.08万股
- 最 低 0.8431
- 昨 收 0.8371
- 总市值 1.59亿
- 52周最高 1.48
- 市盈率 静 --
- 换手率 2.84%
- 52周最低 0.2911
- 委 比 98.90%
- 总股本 1.77亿
- 历史最高 27.50
- 量 比 2.02
- 振 幅 11.58%
- 历史最低 0.2911
- 每 手 1
- 风险率 0.21%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多谷歌投建800MW太阳能项目
根据Swift Current Energy报告称，已完成了谷歌对其位于伊利诺伊州南部的800MWdc双黑钻石太阳能项目的税收股权投资。 该项目位于伊利诺伊州斯...
08-22 10:42
巨头围攻一个光明顶
MNC巨头们在围攻一个“光明顶”。 这个“光明顶”恰恰是血友病领域，作为近20年来FDA批准的*用于治疗A型血友病的创新药，罗氏艾美赛珠单抗Hemlibra自...
08-15 09:57
Earnings Update: Here's Why Analysts Just Lifted Their Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Price Target To US$3.80
The analysts might have been a bit too bullish on Sangamo Therapeutics, Inc. (N...
08-09 18:17
AD研发潮再起？一天两笔合作，近35亿美元流向神经退行性疾病领域
21世纪经济报道记者 韩利明 上海报道 同一天内，神经退行性疾病迎来两笔巨额交易，阿尔茨海默病（AD）领域的研发热潮或再被“引爆”。...
08-08 20:31
Roche evaluating selling cancer startup Flatiron Health - FT
Roche (OTCQX:RHHBY) is considering selling cancer data startup Flatiron Health. Roche is working with Citigroup to look at options for Flatiron, which the Swiss pharma giant acquired in 2018 for $1.9 ...
08-07 21:22
美股牛股 | 光纤股Lumen隔夜涨93%，获50亿美元AI大单；Vimeo绩后涨23.4%
Lumen隔夜涨93%，获50亿美元AI相关产品订单；Vimeo隔夜涨23.4%，Q2业绩大超预期>>
08-07 20:16
快讯 | 罗氏签署20亿美元协议布局阿尔茨海默疗法
罗氏旗下基因泰克(Genentech)与基因疗法公司Sangamo Therapeutics签署了一项协议，旨在开发包括阿尔茨海默病在内的神经退行性疾病的AA...
08-07 15:23
Sangamo Therapeutics Expects FY24 GAAP Basis Total Operating Expenses Of Approximately $150M - $170M
It expect non-GAAP total operating expenses, excluding estimated non-cash stock-based compensation expense of approximately $13 million, impairment expense of approximately $6 million, and depreciation and
08-07 05:57
Sangamo Therapeutics Q2 2024 GAAP EPS $(0.18) Misses $(0.16) Estimate, Sales $356.000K Miss $8.260M Estimate
Sangamo Therapeutics (NASDAQ:SGMO) reported quarterly losses of $(0.18) per share which missed the analyst consensus estimate of $(0.16) by 12.5 percent. The company reported quarterly sales of $356.000 thousand which
08-07 05:29
快讯 | sangamo therapeutics第二季度每股收益美元指数-0.18对比IBES估计美元指数-0.15
Sangamo Therapeutics Q2 EPS USD -0.18 Vs. IBES Estimate USD -0.15
08-07 04:01
